Report

reporttype1Version of Safety Report ID2receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10149944serious1Date Last Updated02/06/2014receiptdateformat102companynumbFR-ACTAVIS-2014-08536occurcountryFRseriousnessother1duplicate1Date Received02/05/2014transmissiondate12/12/2014primarysourcecountryFR

Primary Source

reportercountryFRqualification1

Patient

Onset Age42Unit of Onset AgeyearsWeight67SexMale

Contents

Reaction
- 1)
- 2)
- 3)
- 4)
- 5)
- 6)
Drug

Reaction

1)

reactionmeddraversionpt17.0ReactionDeliriumOutcomeRecovered/resolved

2)

reactionmeddraversionpt17.0ReactionRoad traffic accidentOutcomeRecovered/resolved

3)

reactionmeddraversionpt17.0ReactionPhotopsiaOutcomeRecovered/resolved

4)

reactionmeddraversionpt17.0ReactionFeeling abnormalOutcomeRecovered/resolved

5)

reactionmeddraversionpt17.0ReactionProduct substitution issueOutcomeUnknown

6)

reactionmeddraversionpt17.0ReactionSuicide attemptOutcomeRecovered/resolved

Drug

1)

drugcharacterization1medicinalproductSERTRALINEdrugbatchnumbUNKNOWNdrugauthorizationnumb077663drugstructuredosagenumb50drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugcumulativedosagenumb350drugcumulativedosageunit003drugdosagetext50 MG, DAILYdrugdosageformCAPSULEdrugadministrationroute048drugindicationDYSTHYMIC DISORDERdrugstartdateformat102drugstartdate08/04/2014drugenddateformat102drugenddate15/04/2014actiondrug1

openFDA Info on Medication

Application NumberANDA077670, ANDA077864, ANDA077397Brand NameSERTRALINEGeneric NameSERTRALINE, SERTRALINE HYDROCHLORIDEManufacturers Lupin Pharmaceuticals, Inc., Hikma Pharmaceuticals USA Inc., Exelan Pharmaceutic ... product_ndc 68180-351, 68180-352, 68180-353, 0143-9655, 0143-9656, 0143-9654, 76282-212, 762 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI312938, 312940, 312941spl_id 78d3579a-260f-4bb2-95f2-8ee8a60fae18, f35de481-61af-428e-abb4-a267238b3959, 5c8d ... spl_set_id 42120ff8-b353-4632-9ea9-54de9a698724, f9641190-9151-4f7e-89ff-1e7a818c30ee, 2dac ... Package NDC 68180-351-06, 68180-351-08, 68180-351-09, 68180-351-01, 68180-351-03, 68180-352- ... UNIIUTI8907Y6X

2)

drugcharacterization1medicinalproductZYPREXA VELOTABdrugbatchnumbUNKNOWNdrugstructuredosagenumb20drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext20 MG, DAILYdrugadministrationroute048drugindicationPSYCHOTIC DISORDERdrugstartdateformat602drugstartdate//1998

3)

drugcharacterization1medicinalproductZYPREXA VELOTABdrugbatchnumbUNKNOWNdrugstructuredosagenumb15drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext15 MG, DAILYdrugadministrationroute048

Report Duplicate

duplicatesourceWATSONduplicatenumbFR-ACTAVIS-2014-08536

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

6)

Drug

1)

openFDA Info on Medication

2)

3)

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us